HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A soluble form of lymphocyte activation gene-3 (IMP321) induces activation of a large range of human effector cytotoxic cells.

Abstract
The principal antitumor immune response is mediated through the activation of type 1 cytotoxic (Tc1) CD8 T cells, NK cells, and monocytes/macrophages. In this study, we investigated the potency of a clinical-grade soluble form of lymphocyte activation gene-3 protein (IMP321), a physiological high-affinity MHC class II binder, at inducing in PBMCs an appropriate cytotoxic-type response in short-term ex vivo assays. We found that IMP321 binds to a minority (<10%) of MHC class II + cells in PBMCs, including all myeloid dendritic cells, and a small fraction of monocytes. Four hours after addition of IMP321 to PBMCs, these myeloid cells produce TNF-alpha and CCL4 as determined by intracellular staining. At 18 h, 1% of CD8+ T cells and 3.7% NK cells produce Tc1 cytokines such as IFN-gamma and/or TNF-alpha (mean values from 60 blood donors). Similar induction was observed in metastatic cancer patient PBMCs, but the values were lower for the NK cell subset. Early APC activation by IMP321 is needed for this Tc1-type activation because pure sorted CD8+ T cells could not be activated by IMP321. Only Ag-experienced, fully differentiated granzyme+ CD8 T cells (effector and effector memory but not naive or central memory T cells) are induced by IMP321 to full Tc1 activation. In contrast to IMP321, TLR1-9 agonists induce IL-10 and are therefore unable to induce this Tc1 IFN-gamma+ response. Thus, IMP321 has many properties that confirm its potential to be a new class of immunopotentiator in cancer patients.
AuthorsChrystelle Brignone, Caroline Grygar, Manon Marcu, Knut Schäkel, Frédéric Triebel
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 179 Issue 6 Pg. 4202-11 (Sep 15 2007) ISSN: 0022-1767 [Print] United States
PMID17785860 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antigens, CD
  • Chemokines
  • Cytokines
  • Recombinant Fusion Proteins
  • Toll-Like Receptors
  • Interleukin-10
  • Lymphocyte Activation Gene 3 Protein
  • Lag3 protein, human
  • soluble LAG-3 protein, human
Topics
  • Antigens, CD (genetics, metabolism, physiology)
  • CD8-Positive T-Lymphocytes (cytology, immunology, metabolism)
  • Cell Proliferation
  • Chemokines (biosynthesis)
  • Cytokines (biosynthesis)
  • Dendritic Cells (immunology, metabolism)
  • Humans
  • Immunity, Active
  • Immunity, Innate
  • Immunologic Memory
  • Interleukin-10 (metabolism)
  • Killer Cells, Natural (immunology, metabolism)
  • Leukocytes, Mononuclear (immunology, metabolism)
  • Lymphocyte Activation (immunology)
  • Myeloid Cells (immunology, metabolism)
  • Protein Binding (immunology)
  • Recombinant Fusion Proteins (genetics, metabolism, physiology)
  • Solubility
  • T-Lymphocytes, Cytotoxic (classification, immunology, metabolism)
  • Toll-Like Receptors (agonists)
  • Lymphocyte Activation Gene 3 Protein

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: